id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3332462,bdee4922-d6cd-477e-a75b-e4c82cd18eab,Q1,CHAMBER HILL STRATEGIES,400645947,"MAYO COLLABORATIVE SERVICES, INC.",2025,first_quarter,MED,"Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-04-12T18:04:45-04:00
3533324,bdee4922-d6cd-477e-a75b-e4c82cd18eab,Q1,CHAMBER HILL STRATEGIES,400645947,"MAYO COLLABORATIVE SERVICES, INC.",2025,first_quarter,MED,"Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2025-04-12T18:04:45-04:00